[en] Multiple factors such as genetic and extraneous causes (drugs, toxins, adverse psychological events) contribute to neuro-psychiatric conditions. In a subgroup of these disorders, systemic folate deficiency has been associated with macrocytic anemia and neuropsychiatric phenotypes. In some of these, despite normal systemic levels, folate transport to the brain is impaired in the so-called cerebral folate deficiency (CFD) syndromes presenting as developmental and psychiatric disorders. These include infantile-onset CFD syndrome, infantile autism with or without neurologic deficits, a spastic-ataxic syndrome and intractable epilepsy in young children expanding to refractory schizophrenia in adolescents, and finally treatment-resistant major depression in adults. Folate receptor alpha (FRalpha) autoimmunity with low CSF N(5)-methyl-tetrahydrofolate (MTHF) underlies most CFD syndromes, whereas FRalpha gene abnormalities and mitochondrial gene defects are rarely found. The age at which FRalpha antibodies of the blocking type emerge, determines the clinical phenotype. Infantile CFD syndrome and autism with neurological deficits tend to be characterized by elevated FRalpha antibody titers and low CSF MTHF. In contrast, in infantile autism and intractable schizophrenia, abnormal behavioral signs and symptoms may wax and wane with fluctuating FRalpha antibody titers over time accompanied by cycling changes in CSF folate, tetrahydrobiopterin (BH4) and neurotransmitter metabolites ranging between low and normal levels. We propose a hypothetical model explaining the pathogenesis of schizophrenia. Based on findings from clinical, genetic, spinal fluid and MRI spectroscopic studies, we discuss the neurochemical changes associated with these disorders, metabolic and regulatory pathways, synthesis and catabolism of neurotransmitters, and the impact of oxidative stress on the pathogenesis of these conditions. A diagnostic algorithm and therapeutic regimens using high dose folinic acid, corticosteroids and milk-free diet is presented which has proven to be beneficial in providing adequate folate to the brain and decreasing the FRalpha autoantibody titer in those positive for the antibody.
Disciplines :
Psychiatry Pediatrics Neurology
Author, co-author :
RAMAEKERS, Vincent ; Centre Hospitalier Universitaire de Liège - CHU > Centre de référence de l'autisme de Liège (CRAL)
Sequeira, J. M.; Department of Medicine, Downstate Medical Center, State University New York, USA
Quadros, E. V.; Department of Medicine, Downstate Medical Center, State University New York, USA
Language :
English
Title :
The basis for folinic acid treatment in neuro-psychiatric disorders.
E. Reynolds Vitamin B12, folic acid, and the nervous system Lancet Neurol. 5 2006 949 960
S.D. Shorvon, M.W.P. Carney, I. Chanarin, and E.H. Reynolds The neuropsychiatry of megaloblastic anaemia BMJ 281 1980 1036 1038
E.G. Lever, R.D. Elwes, A. Williams, and E.H. Reynolds Subacute combined degeneration of the spinal cord due to folate deficiency: response to methyl folate treatment J. Neurol. Neurosurg. Psychiatry 49 10 1986 1203 1207
E.H. Reynolds The neurology of folic acid deficiency Handb. Clin. Neurol. 120 2014 927 943
S.D. Shorvon, and E.H. Reynolds Folate deficiency and peripheral neuropathy M.I. Botez, E.H. Reynolds, Folic Acid in Neurology, Psychiatry and Internal Medicine 1979 Raven Press New York 413 421
S.J. Lewis, D.A. Lawlor, G. Davey Smith, and et al. The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis Mol. Psychiatry 11 2006 352 360
M.I. Ramos, L.H. Allen, D.M. Mungas, and et al. Low folate status is associated with impaired cognitive function and dementia in the Sacramento area Latino study on aging Am. J. Clin. Nutr. 82 2005 1346 1352
P. Sneath, I. Chanarin, H.M. Hodkinson, C.K. McPhearson, and E.H. Reynolds Folate status in a geriatric population and its relation to dementia Age Ageing 2 1973 177 182
J.S. Goodwin, J.M. Goodwin, and P.J. Garry Association between nutritional status and cognitive functioning in a healthy elderly population JAMA 249 1983 2917 2921
M.I. Botez, F. Fontaine, T. Botez, and J. Bachevalier Folate-responsive neurological and mental disorders: report of 16 cases Eur. Neurol. 16 1977 230 246
L. Corbeel, G. Van den Berghe, J. Jaeken, J. Van Tornout, and R. Eeckels Congenital folate malabsorption Eur. J. Pediatr. 143 1985 284 290
A. Qiu, M. Jansen, A. Sakaris, S.H. Min, S. Chattopadhyay, E. Tsai, and et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption Cell 127 2006 917 928
V.T. Ramaekers, M. Häusler, T. Opladen, G. Heimann, and N. Blau Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution Neuropediatrics 33 2002 301 308
V.T. Ramaekers, and N. Blau Cerebral folate deficiency Dev. Med. Child. Neurol. 46 2004 843 851
V.T. Ramaekers, J.M. Sequeira, and E.V. Quadros Clinical recognition and aspects of cerebral folate deficiencies Clin. Chem. Lab. Med. 51 2013 545 554
V.T. Ramaekers, S.P. Rothenberg, J.M. Sequeira, T. Opladen, N. Blau, E.V. Quadros, and et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome N. Engl. J. Med. 352 2005 1985 1991
S.P. Rothenberg, M.P. da Costa, J.M. Sequeira, J. Cracco, J.L. Roberts, J. Weedon, and et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect N. Engl. J. Med. 350 2004 134 142
M. Grapp, A. Wrede, M. Schweizer, S. Hüwel, H.J. Galla, N. Snaidero, M. Simons, J. Bückers, P.S. Low, H. Urlaub, J. Gärtner, and R. Steinfeld Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma Nat. Commun. 4 2013 2123
R. Steinfeld, M. Grapp, R. Kraetzner, S. Dreha-Kulaczewski, G. Helms, P. Dechent, R. Wevers, S. Grosso, and J. Gärtner Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism Am. J. Hum. Genet. 85 3 2009 354 363
M. Grapp, I.A. Just, T. Linnankivi, P. Wolf, T. Lücke, M. Häusler, J. Gärtner, and R. Steinfeld Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency Brain 135 2012 2022 2031
V.T. Ramaekers, J. Weis, J.M. Sequeira, E.V. Quadros, and N. Blau Mitochondrial complex I encephalomyopathy and cerebral 5-methyltetrahydrofolate deficiency Neuropediatrics 38 2007 184 187
A. Garcia-Cazorla, E.V. Quadros, A. Nascimento, M.T. Garcia-Silva, P. Briones, J. Montoya, and et al. Mitochondrial diseases associated with cerebral folate deficiency Neurology 70 2008 1360 1362
K. Tanji, E.A. Schon, S. DiMauro, and E. Bonilla Kearns-Sayre syndrome: oncocytic transformation of choroid plexus epithelium J. Neurol. Sci. 178 2000 29 36
V.T. Ramaekers, S.I. Hansen, J. Holm, T. Opladen, J. Senderek, M. Häusler, and et al. Reduced folate transport to the CNS in female Rett patients Neurology 61 2003 506 515
V.T. Ramaekers, J.M. Sequeira, R. Artuch, N. Blau, T. Temudo, A. Ormazabal, and et al. Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome Neuropediatrics 38 2007 179 183
V.T. Ramaekers, B. Thöny, J.M. Sequeira, M. Ansseau, P. Philippe, F. Boemer, V. Bours, and E.V. Quadros Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies Mol. Genet. Metab. 113 4 2014 307 314
R.E. Frye, J.M. Sequeira, E. Quadros, and D. Rossignol Folate receptor alpha autoantibodies modulate thyroid function in autism spectrum disorder N.A.J. Med. Sci. 7 2 2014 53 56
J.A. Piedrahita, B. Oetama, G. Bennett, J. van Waes, B.A. Kamen, J. Richardson, and et al. Mice lacking the folic acid- binding protein Folbp1 are defective in early embryonic development Nat. Genet. 23 1999 228 232
O. Spiegelstein, L.E. Mitchell, M.Y. Merriweather, N.J. Wicker, Q. Zhang, E.J. Lammer, and R.H. Finnell Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation Dev. Dyn. 231 1 2004 221 231
R.H. Finnell, A. Gould, O. Spiegelstein, Pathobiology and genetics of neural tube defects, Epilepsia 44 () Suppl. 3: 14-23. Review.
R.J. Schmidt, D.J. Tancredi, S. Ozonoff, R.L. Hansen, J. Hartiala, H. Allayee, and et al. Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (Childhood Autism Risks from Genetics and Environment) case-control study Am. J. Clin. Nutr. 96 2012 80 89
P. Surén, C. Roth, M. Bresnahan, M. Haugen, M. Hornig, D. Hirtz, K.K. Lie, W.I. Lipkin, P. Magnus, T. Reichborn- Kjennerud, S. Schjølberg, G. Davey Smith, A.S. ∅yen, E. Susser, and C. Stoltenberg Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children JAMA 309 6 2013 570 577
V.T. Ramaekers, E.V. Quadros, and J.M. Sequeira Role of folate receptor autoantibodies in infantile autism Mol. Psychiatry 18 3 2013 270 271
I. Shapira, J.M. Sequeira, and E.V. Quadros Folate receptor autoantibodies in pregnancy related complications Birth Defects Res. A. Clin. Mol. Teratol. 2015 Sep 21 10.1002/bdra.23436 [Epub ahead of print] PubMed PMID: 26390016
V.T. Ramaekers, N. Blau, J.M. Sequeira, M.C. Nassogne, and E.V. Quadros Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits Neuropediatrics 38 2007 276 281
P. Moretti, T. Sahoo, K. Hyland, T. Bottiglieri, S. Peters, D. del Gaudio, and et al. Cerebral folate deficiency with developmental delay, autism, and response to folinic acid Neurology 64 2005 1088 1090
F.J. Hansen, and N. Blau Cerebral folate deficiency: life-changing supplementation with folinic acid Mol. Genet. Metab. 84 2005 371 373
O. Hasselmann, N. Blau, V.T. Ramaekers, E.V. Quadros, J.M. Sequeira, and M. Weissert Cerebral folate deficiency and CNS inflammatory markers in Alpers disease Mol. Genet. Metab. 99 2010 58 61
S.U. Steele, S.M. Cheah, A. Veerapandiyan, W. Gallentine, E.C. Smith, and M.A. Mikati Electroencephalographic and seizure manifestations in two patients with folate receptor autoimmune antibody-mediated primary cerebral folate deficiency Epilepsy Behav. 24 4 2012 507 512
N. Gordon Cerebral folate deficiency Dev. Med. Child. Neurol. 51 3 2009 180 182
V. Ramaekers, and E.V. Quadros Folate receptor autoimmunity in cerebral folate deficiency R.C. Dale, A. Vincent, Inflammatory and Autoimmune Disorders of the Nervous System in Children 2010 Mac Keith Press London 302 315
R. Zhao, N. Diop-Bove, M. Visentin, and I.D. Goldman Mechanisms of membrane transport of folates into cells and across Epithelia Annu. Rev. Nutr. 31 2011 177 201
P.J. Bagley, and J. Selhub A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells Proc. Natl. Acad. Sci. U. S. A. 95 1998 13217 13220
P.T. Clayton, I. Smith, B. Harding, K. Hyland, J.V. Leonard, and R.J. Leeming Subacute combined degeneration of the cord, dementia and Parkinsonism due to an inborn error of folate metabolism J. N. N. P. 49 1986 920 927
R. Obeid, and W. Herrmann Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia F.E.B.S. Lett. 580 2006 2994 3005
R. Obeid, P. Kostopoulos, J.P. Knapp, M. Kasoha, G. Becker, K. Fassbender, W. Herrmann, and L. Schaevitz Biomarkers of Folate and Vitamin B12 Are Related in Blood and Cerebrospinal Fluid Clin. Chem. 53 2 2007 326 333
T. Bottiglieri, M. Laundy, R. Crellin, B.K. Toone, M.W. Carney, and E.H. Reynolds Homocysteine, folate, methylation, and monoamine metabolism in depression J. Neurol. Neurosurg. Psychiatry 69 2 2000 228 232
L.R. Schaevitz, and J.E. Berger-Sweeney Gene-environment interactions and epigenetic pathways in autism: the importance of one-carbon metabolism I. L. A. R. J. 53 3-4 2012 322 340
T. Opladen, N. Blau, and V.T. Ramaekers Effect of antiepileptic drugs and reactive oxygen species on folate receptor 1 (FOLR1)-dependent 5-methyltetrahydrofolate transport Mol. Genet. Metab. 101 1 2010 48 54
S.B. Aylett, V. Neergheen, I.P. Hargreaves, S. Eaton, J.M. Land, S. Rahman, and S.J. Heales Levels of 5-methyltetrahydrofolate and ascorbic acid in cerebrospinal fluid are correlated: implications for the accelerated degradation of folate by reactive oxygen species Neurochem. Int. 63 8 2013 750 755
S.A. Lipton, W.K. Kim, Y.B. Choi, S. Kumar, D.M. D'Emilia, P.V. Rayudu, D.R. Arnelle, and J.S. Stamler Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor Proc. Natl. Acad. Sci. U. S. A. 94 1997 5923 5928
C.R. Yang, and K.A. Svensson Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia Pharmacol. Ther. 120 2008 317 332
M. Delgado-Esteban, A. Almeida, and J.M. Medina Tetrahydrobiopterin deficiency increases neuronal vulnerability to hypoxia J. Neurochem. 82 5 2002 1148 1159
H.L. Kim, and Y.S. Park Maintenance of cellular tetrahydrobiopterin homeostasis B.M.B. Rep. 43 9 2010 584 592
E.R. Werner, N. Blau, and B. Thöny Tetrahydrobiopterin: biochemistry and pathophysiology Biochem. J. 438 3 2011 397 414
B. Blanchard-Fillion, J.M. Souza, T. Friel, G.C. Jiang, K. Vrana, V. Sharov, C. Barrón, L. Schöneich, C. Quijano, B. Alvarez, R. Radi, S. Przedborski, G.S. Fernando, J. Horwitz, and H. Ischiropoulos Nitration and inactivation of tyrosine hydroxylase by peroxynitrite J. Biol. Chem. 276 49 2001 46017 46023
D.M. Kuhn, and T.J. Geddes Peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidation. Coincident nitration of enzyme tyrosyl residues has minimal impact on catalytic activity J. Biol. Chem. 274 42 1999 29726 29732
R. Deth, C. Muratore, J. Benzecry, V.A. Power-Charnitsky, and M. Waly How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis Neurotoxicology 29 1 2008 190 201
B. Lozoff Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction J. Nutr. 141 4 2011 740S 746S
K.E. Brunette, P.V. Tran, J.D. Wobken, E.S. Carlson, and M.K. Georgieff Gestational and neonatal iron deficiency alters apical dendrite structure of CA1 pyramidal neurons in adult rat hippocampus Dev. Neurosci. 32 3 2010 238 248
A. Takeda Zinc homeostasis and functions of zinc in the brain Biometals 14 3-4 2001 343 351
A. Takeda Manganese action in brain function Brain Res. Rev. 41 1 2003 79 87
J.Y. Uriu-Adams, R.E. Scherr, L. Lanoue, and C.L. Keen Influence of copper on early development: prenatal and postnatal Considerations Biofactors 36 2 2010 136 152
S. Johnson Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson's disease? Med. Hypotheses 56 5 2001 641 645
D. Benton, and R.T. Donohoe The effects of nutrients on mood Public Health Nutr. 2 3A 1999 403 409
R.E. Frye, and S.J. James Metabolic pathology of autism in relation to redox metabolism Biomark. Med. 8 3 2014 321 330
S.J. James, S. Melnyk, S. Jernigan, M.A. Cleves, C.H. Halsted, D.H. Wong, P. Cutler, K. Bock, M. Boris, J.J. Bradstreet, S.M. Baker, and D.W. Gaylor Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141B 8 2006 947 956
P.M. Ueland Choline and betaine in health and disease J. Inherit. Metab. Dis. 34 1 2011 3 15
V. Boshnjaku, K.W. Shim, T. Tsurubuchi, S. Ichi, E.V. Szany, G. Xi, B. Mania-Farnell, D.G. McLone, T. Tomita, and C.S. Mayanil Nuclear localization of folate receptor alpha: a new role as a transcription factor Sci. Rep. 2 2012 980
V.T. Ramaekers, J.M. Sequeira, N. Blau, and E.V. Quadros A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome Dev. Med. Child. Neurol. 50 2008 346 352
R. Lambrot, C. Xu, S. Saint-Phar, G. Chountalos, T. Cohen, M. Paquet, M. Suderman, M. Hallett, and S. Kimmins Low paternal dietary folate alters the mouse sperm epigenome and is associated with negative pregnancy outcomes Nat. Commun. 4 2013 2889
B.G. Swayne, A. Kawata, N.A. Behan, A. Williams, M.G. Wade, A.J. Macfarlane, and C.L. Yauk Investigating the effects of dietary folic acid on sperm count, DNA damage and mutation in Balb/c mice Mutat. Res. 737 1-2 2012 1 7
M.S. Zandi, S.R. Irani, B. Lang, P. Waters, P.B. Jones, P. McKenna, A.J. Coles, A. Vincent, and B.R. Lennox Disease- relevant autoantibodies in first episode schizophrenia J.Neurol. 258 4 2011 686 688
T. Iizuka, F. Sakai, T. Ide, T. Monzen, S. Yoshii, M. Ligaya, K. Suzuki, D.R. Lynch, N. Suzuki, T. Hata, and J. Dalmau Anti-NMDA receptor encephalitis in Japan: long-term outcome with tumor removal Neurology 70 7 2008 504 511
C.G. Bien, A. Vincent, M.H. Barnett, A.J. Becker, I. Bluemcke, F. Graus, K.A. Jellinger, D.E. Reuss, T. Ribalta, J. Schlegel, I. Sutton, H. Lassmann, and J. Bauer Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis Brain 135 2012 1622 1638
S.H. Schultz, S.W. North, and C.G. Shields Schizophrenia: a review Am. Fam. Physician 75 2007 1821 1829
M.M. Picchioni, and R.M. Murray Schizophrenia B. M. J. 335 2007 91 95
B.L. Roth Contributions of molecular biology to antipsychotic drug discovery: promises fulfilled or unfulfilled? Dialogues Clin. Neurosci. 8 3 2006 303 309
M.J. Owen, N.M. Williams, and M.C. O'Donovan The molecular genetics of schizophrenia: new findings promise new insights Mol. Psychiatry 9 2004 14 27
S.M. Stahl Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia CN.S. Spectr. 4 2007 265 268
J.T. Coyle NMDA receptor and schizophrenia: a brief history Schizophr. Bull. 38 5 2012 920 926
A.R. Mohn, R.R. Gainetdinov, M.G. Caron, and B.H. Koller Mice with reduced NMDA receptor expression display behaviors related to schizophrenia Cell 98 1999 427 436
P.M. Thompson, C. Vidal, J.N. Giedd, P. Gochman, J. Blumenthal, R. Nicolson, A.W. Toga, and J.L. Rapoport Mapping adolescent brain change reveals dynamic wave of accelerating grey matter loss in very early-onset schizophrenia P. N. A. S. 98 2001 11650 11655
T.I. Lidsky, Reevaluation of the mesolimbic hypothesis of antipsychotic drug action, Schizophr. Bull. 21(1) () 67-74. Review.
M. Lamelle, and A. Abi-Dargham Dopamine in the history of the schizophrenic brain: recent contributions of brain-imaging Studies Dialogues Clin. Neurosci. 2 4 2000 359 372
N. Ginovart, and S. Kapur Role of dopamine D(2) receptors for antipsychotic activity Handb. Exp. Pharmacol. 212 2012 27 52
J.T. Coyle, D. Balu, M. Benneyworth, A. Basu, and A. Roseman Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia Dialogues Clin. Neurosci. 12 3 2010 359 382
J.K. Seamans, and C.R. Yang The principal features and mechanisms of dopamine modulation in the prefrontal cortex Prog. Neurobiol. 74 1 2004 1 58
L.D. Selemon, and N. Zecevic Schizophrenia: a tale of two critical periods for prefrontal cortical development Transl. Psychiatry 5 2015 e623
M.B. Knable, and D.R. Weinberger Dopamine, the prefrontal cortex and schizophrenia J. Psychopharmacol. 11 2 1997 123 131
A.E. Timms, M.O. Dorschne, J. Wechsler, K.Y. Choi, R. Kirkwood, S. Girirajan, C. Baker, E.E. Eichler, O. Korvatska, K.W. Roche, M.S. Horwitz, and D.W. Tsuang Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families J.A.M.A. Psychiatry 70 6 2013 582 590
T.L. Schwartz, S. Sachdeva, and S.M. Stahl Genetic data supporting the NMDA glutamate receptor hypothesis for Schizophrenia Curr. Pharm. Des. 18 12 2012 1580 1592
C. Kehrer, N. Maziashvili, T. Dugladze, and T. Gloveli Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia Front. Mol. Neurosci. 1 2008 6
J. González-Maeso, and S.C. Sealfon Psychedelics and schizophrenia Trends Neurosci. 32 4 2009 225 232
M.J. Gandal, R.J. Anderson, E.N. Billingslea, G.C. Carlson, T.P. Roberts, and S.J. Siegel Mice with reduced NMDA receptor expression:more consistent with autism than schizophrenia? Genes Brain Behav. 11 6 2012 740 750
B.R. Hutto Folate and cobalamin in psychiatric illness Compr. Psychiatry 38 6 1997 305 314
B. Regland Schizophrenia and single-carbon metabolism, Prog. Neuropsychopharmacol Biol. Psychiatry 29 7 2005 1124 1132
P.S. Godfrey, B.K. Toone, M.W. Carney, T.G. Flynn, T. Bottiglieri, M. Laundy, I. Chanarin, and E.H. Reynolds Enhancement of recovery from psychiatric illness by methylfolate Lancet 336 1990 392 395
J.M. Freeman, J.D. Finkelstein, and S.H. Mudd Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity N. Engl. J. Med. 292 10 1975 491 496
P.I. Ho, D. Ortiz, E. Rogers, and T.B. Shea Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage J. Neurosci. Res. 70 5 2002 694 702
K.S. McCully Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and Inflammation Ann. Clin. Lab. Sci. 39 3 2009 219 232
E. Bonfoco, D. Krainc, M. Ankarcrona, P. Nicotera, and S.A. Lipton Apoptosis and necrosis: two distinct events induced respectively by mild and intense insults with NMDA or nitric oxide/superoxide in cortical cell cultures Proc. Natl. Acad. Sci. U. S. A. 91 1995 7162 7166
E. Bonfoco, M. Leist, B. Zhivotovsky, and et al. Cytoskeletal breakdown and apoptosis elicited by NO-donors in cerebellar granule cells require NMDA-receptor activation J. Neurochem. 67 1996 2484 2493
J.K. Yao, S. Leonard, and R.D. Reddy Increased nitric oxide radicals in postmortem brain from patients with schizophrenia Schizophr. Bull. 30 4 2004 923 934
R.F. Nasyrova, D.V. Ivashchenko, M.V. Ivanov, and N.G. Neznanov Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects Front. Physiol. 6 2015 139
G.I. Papakostas, R.C. Shelton, J.M. Zajecka, T. Bottiglieri, J. Roffman, C. Cassiello, S.M. Stahl, and M. Fava Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial J. Clin. Psychiatry 75 8 2014 855 863
M. Fava, and D. Mischoulon Folate in depression: efficacy, safety, differences in formulations, and clinical issues J. Clin. Psychiatry 70 Suppl. 5 2009 12 17
S.N. Young, and A.M. Ghadirian Folic acid and psychopathology, Prog. Neuropsychopharmacol Biol. Psychiatry 13 6 1989 841 863
M.I. Botez, S.N. Young, J. Bachevalier, and S. Gauthier Effect of folic acid and vitamin B12 deficiencies on 5-hydroxyindoleacetic acid in human cerebrospinal fluid Ann. Neurol. 12 5 1982 479 484
M.W. Roman, and F.H. Bembry L-methylfolate (Deplin®): a new medical food therapy as adjunctive treatment for Depression Issues Ment. Health Nurs. 32 2 2011 142 143
S.M. Stahl L-methylfolate: a vitamin for your monoamines J. Clin. Psychiatry 69 9 2008 1352 1353
P.P. Lee, and R.L. Schilsky Inhibition of thymidylate synthase by the diastereoisomers of leucovorin Cancer Chemother. Pharmacol. 26 4 1990 273 277
D.R. Makulu, E.F. Smith, and J.R. Betino Lack of dihydrofolate reductase activity in brain tissue of mammalian species: possible implications J. Neurochem. 21 1 1973 241 245
S. Banka, H.J. Blom, J. Walter, M. Aziz, J. Urquhart, C.M. Clouthier, G.I. Rice, A.P. de Brouwer, E. Hilton, G. Vassallo, A. Will, D.E. Smith, Y.M. Smulders, R.A. Wevers, R. Steinfeld, S. Heales, Y.J. Crow, J.N. Pelletier, S. Jones, and W.G. Newman Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency Am. J. Hum. Genet. 88 2 2011 216 225
A.M. Knivsberg, K.L. Reichelt, T. Høien, and M. Nødland A randomised, controlled study of dietary intervention in autistic syndromes Nutr. Neurosci. 5 4 2002 251 261
P. Whiteley, P. Shattock, A.M. Knivsberg, A. Seim, K.L. Reichelt, L. Todd, K. Carr, and M. Hooper Gluten- and casein- free dietary intervention for autism spectrum conditions Front. Hum. Neurosci. 6 2013 344